A newly available drug may improve the effectiveness of immunotherapy in hard-to-treat cancers of the upper urinary tract, suggests a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.

For the study, published July 5 in Nature Communications, the research...

Title of Proposal:  Reinterpreting the pathogenicity of VUS in UC patients from diverse ancestries

PI: Bishoy Faltas | WCM | Medicine
Co-PI: Jonathan Rosenberg | MSKCC | Medicine


Weill Cornell Medicine Faltas Lab 1300 York Avenue, 6th Floor New York, NY 10022 Phone: 646-962-2072